Related Experiment Videos
Selective immunotoxic effects in mice treated with the adenosine deaminase inhibitor 2'-deoxycoformycin
Abstract:
Mice were administered the adenosine deaminase inhibitor 2'-deoxycoformycin by daily intraperitoneal injection for five days and evaluated 24 h, 72 h and 6 days after the final dose. Spleen weight was decreased in treated mice for up to 6 days after treatment whereas body weight was significantly affected only at 24 h in mice administered 4 micrograms 2'-deoxycoformycin/g of body weight. The number and relative percentage of circulating lymphocytes were decreased 24 and 72 h after the last injection. Lymphoproliferative responses to T cell mitogens were suppressed for at least 72 h post-treatment whereas the mixed lymphocyte response was normal at 24 h but was depressed at 72 h post-treatment. Conversely, natural killer cell activity was greater in treated mice than in controls for the entire observation period. Data from cell surface marker analysis provided indirect evidence that natural killer effector cells lack sensitivity to 2'-deoxycoformycin. The antibody responses of mice treated with 2 or 4 micrograms 2'-deoxycoformycin/g over four days prior to or after immunization with sheep erythrocytes were suppressed or enhanced, respectively, compared to controls. These results indicate selective effects of 2'-deoxycoformycin on immune function and suggest that subpopulations of lymphocytes differ in the degree of sensitivity to 2'-deoxycoformycin.
Insights
2'-deoxycoformycin selectively impacts mouse immune function, decreasing lymphocytes and T cell responses while enhancing natural killer cell activity. This suggests varying lymphocyte sensitivity to this adenosine deaminase inhibitor.
Area of Science:
- Immunology
- Pharmacology
Background:
- Adenosine deaminase (ADA) is crucial for lymphocyte function.
- 2'-deoxycoformycin is a potent ADA inhibitor.
Purpose of the Study:
- To investigate the selective effects of 2'-deoxycoformycin on various immune cell populations and functions in mice.
Main Methods:
- Mice received daily intraperitoneal injections of 2'-deoxycoformycin.
- Evaluations included spleen and body weight, circulating lymphocyte counts, lymphoproliferative responses, mixed lymphocyte responses, natural killer cell activity, and antibody production.
Main Results:
- Decreased spleen weight and circulating lymphocytes observed post-treatment.
- Suppressed T cell mitogen responses and mixed lymphocyte responses at 72 hours.
- Enhanced natural killer cell activity throughout the observation period.
- Differential effects on antibody responses depending on treatment timing relative to immunization.
Conclusions:
- 2'-deoxycoformycin exhibits selective toxicity towards certain lymphocyte subpopulations.
- Immune cell sensitivity to 2'-deoxycoformycin varies, impacting both innate and adaptive immunity.